Somerset Group LLC Abb Vie Inc. Transaction History

Somerset Group LLC

$107 Million
Q3 2024

A detailed history of Somerset Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Somerset Group LLC holds 6,803 shares of ABBV stock, worth $1.22 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

6,803

Previous 6,803 -0.0%

Holding current value

$1.22 Million

Previous $1.17 Million 15.18%

% of portfolio

1.26%

Previous 1.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $95,892 - $109,260	-600 Reduced 8.1%	6,803 $1.24 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $102,997 - $119,235	-771 Reduced 9.43%	7,403 $1.1 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $4,637 - $5,771	-35 Reduced 0.43%	8,174 $1.1 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $2,892 - $3,330	20 Added 0.24%	8,209 $1.31 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $96,817 - $116,109	-700 Reduced 7.87%	8,189 $1.32 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $3,027 - $3,849	-22 Reduced 0.25%	8,889 $1.36 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $42,560 - $48,312	-400 Reduced 4.3%	8,911 $961,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $6,102 - $6,798	58 Added 0.63%	9,311 $1.05 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $20,460 - $22,524	-200 Reduced 2.12%	9,253 $1 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $4,185 - $5,650	52 Added 0.55%	9,453 $1.01 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $807,639 - $947,902	9,401 New	9,401 $823,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Group LLC with notifications on news.

Account

Somerset Group LLC Abb Vie Inc. Transaction History